520 related articles for article (PubMed ID: 25478737)
1. Mesoporous silica as topical nanocarriers for quercetin: characterization and in vitro studies.
Sapino S; Ugazio E; Gastaldi L; Miletto I; Berlier G; Zonari D; Oliaro-Bosso S
Eur J Pharm Biopharm; 2015 Jan; 89():116-25. PubMed ID: 25478737
[TBL] [Abstract][Full Text] [Related]
2. Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization.
Abd-Elrahman AA; El Nabarawi MA; Hassan DH; Taha AA
Drug Deliv; 2016 Nov; 23(9):3387-3398. PubMed ID: 27167529
[TBL] [Abstract][Full Text] [Related]
3. Thermoresponsive mesoporous silica nanoparticles as a carrier for skin delivery of quercetin.
Ugazio E; Gastaldi L; Brunella V; Scalarone D; Jadhav SA; Oliaro-Bosso S; Zonari D; Berlier G; Miletto I; Sapino S
Int J Pharm; 2016 Sep; 511(1):446-454. PubMed ID: 27421910
[TBL] [Abstract][Full Text] [Related]
4. Preparation of efficient quercetin delivery system on Zn-modified mesoporous SBA-15 silica carrier.
Trendafilova I; Szegedi A; Mihály J; Momekov G; Lihareva N; Popova M
Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():285-292. PubMed ID: 28183610
[TBL] [Abstract][Full Text] [Related]
5. Mesoporous silica nanoparticles for enhanced lidocaine skin delivery.
Nafisi S; Samadi N; Houshiar M; Maibach HI
Int J Pharm; 2018 Oct; 550(1-2):325-332. PubMed ID: 30081227
[TBL] [Abstract][Full Text] [Related]
6. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
[TBL] [Abstract][Full Text] [Related]
7. Multilayer encapsulated mesoporous silica nanospheres as an oral sustained drug delivery system for the poorly water-soluble drug felodipine.
Hu L; Sun H; Zhao Q; Han N; Bai L; Wang Y; Jiang T; Wang S
Mater Sci Eng C Mater Biol Appl; 2015 Feb; 47():313-24. PubMed ID: 25492202
[TBL] [Abstract][Full Text] [Related]
8. A focal adhesion kinase inhibitor 16-hydroxy-cleroda-3,13-dien-16,15-olide incorporated into enteric-coated nanoparticles for controlled anti-glioma drug delivery.
Thiyagarajan V; Lin SX; Lee CH; Weng CF
Colloids Surf B Biointerfaces; 2016 May; 141():120-131. PubMed ID: 26851441
[TBL] [Abstract][Full Text] [Related]
9. MCM-41 as a useful vector for rutin topical formulations: synthesis, characterization and testing.
Berlier G; Gastaldi L; Sapino S; Miletto I; Bottinelli E; Chirio D; Ugazio E
Int J Pharm; 2013 Nov; 457(1):177-86. PubMed ID: 24076399
[TBL] [Abstract][Full Text] [Related]
10. Modified mesoporous silica nanoparticles for enhancing oral bioavailability and antihypertensive activity of poorly water soluble valsartan.
Biswas N
Eur J Pharm Sci; 2017 Mar; 99():152-160. PubMed ID: 27993684
[TBL] [Abstract][Full Text] [Related]
11. Mesoporous silica as a carrier for topical application: the Trolox case study.
Gastaldi L; Ugazio E; Sapino S; Iliade P; Miletto I; Berlier G
Phys Chem Chem Phys; 2012 Aug; 14(32):11318-26. PubMed ID: 22785459
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of the effect of permeation enhancers, lipid nanoparticles and colloidal silica on in vivo human skin penetration of quercetin.
Scalia S; Franceschinis E; Bertelli D; Iannuccelli V
Skin Pharmacol Physiol; 2013; 26(2):57-67. PubMed ID: 23207877
[TBL] [Abstract][Full Text] [Related]
13. Hollow mesoporous silica as a high drug loading carrier for regulation insoluble drug release.
Geng H; Zhao Y; Liu J; Cui Y; Wang Y; Zhao Q; Wang S
Int J Pharm; 2016 Aug; 510(1):184-94. PubMed ID: 27262268
[TBL] [Abstract][Full Text] [Related]
14. Imidazolium-based ionic liquid functionalized mesoporous silica nanoparticles as a promising nano-carrier: response surface strategy to investigate and optimize loading and release process for Lapatinib delivery.
Peyvand P; Vaezi Z; Sedghi M; Dalir N; Ma'mani L; Naderi-Manesh H
Pharm Dev Technol; 2020 Nov; 25(9):1150-1161. PubMed ID: 32746669
[TBL] [Abstract][Full Text] [Related]
15. Quercetin encapsulation in modified silica nanoparticles: potential use against Cu(II)-induced oxidative stress in neurodegeneration.
Nday CM; Halevas E; Jackson GE; Salifoglou A
J Inorg Biochem; 2015 Apr; 145():51-64. PubMed ID: 25634813
[TBL] [Abstract][Full Text] [Related]
16. Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells.
Sarkar A; Ghosh S; Chowdhury S; Pandey B; Sil PC
Biochim Biophys Acta; 2016 Oct; 1860(10):2065-75. PubMed ID: 27392941
[TBL] [Abstract][Full Text] [Related]
17. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
Xie Z; Gong H; Liu M; Zhu H; Sun H
J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
[TBL] [Abstract][Full Text] [Related]
18. A transdermal delivery system to enhance quercetin nanoparticle permeability.
Bennet D; Kim S
J Biomater Sci Polym Ed; 2013; 24(2):185-209. PubMed ID: 23565597
[TBL] [Abstract][Full Text] [Related]
19. Preparation, characterization, and evaluation in vivo of Ins-SiO₂-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin.
Zhao X; Shan C; Zu Y; Zhang Y; Wang W; Wang K; Sui X; Li R
Int J Pharm; 2013 Sep; 454(1):278-84. PubMed ID: 23830939
[TBL] [Abstract][Full Text] [Related]
20. Stabilization of quercetin flavonoid in MCM-41 mesoporous silica: positive effect of surface functionalization.
Berlier G; Gastaldi L; Ugazio E; Miletto I; Iliade P; Sapino S
J Colloid Interface Sci; 2013 Mar; 393():109-18. PubMed ID: 23245887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
